Review





Similar Products

94
Miltenyi Biotec reafinitytm
Reafinitytm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reafinitytm/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
reafinitytm - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

99
Luminex hla-fusion-software
Hla Fusion Software, supplied by Luminex, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla-fusion-software/product/Luminex
Average 99 stars, based on 1 article reviews
hla-fusion-software - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Immudex hla matched dcode dextramers
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Hla Matched Dcode Dextramers, supplied by Immudex, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla matched dcode dextramers/product/Immudex
Average 86 stars, based on 1 article reviews
hla matched dcode dextramers - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Proimmune hla b
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Hla B, supplied by Proimmune, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla b/product/Proimmune
Average 86 stars, based on 1 article reviews
hla b - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Huabio Inc hla abc
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Hla Abc, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla abc/product/Huabio Inc
Average 86 stars, based on 1 article reviews
hla abc - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Omixon Inc holotype hla 24 7 kit
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Holotype Hla 24 7 Kit, supplied by Omixon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/holotype hla 24 7 kit/product/Omixon Inc
Average 86 stars, based on 1 article reviews
holotype hla 24 7 kit - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Omixon Inc hla twin software v4 9 0
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Hla Twin Software V4 9 0, supplied by Omixon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla twin software v4 9 0/product/Omixon Inc
Average 86 stars, based on 1 article reviews
hla twin software v4 9 0 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Jackson Laboratory transgenic c57bl 6 mice expressing hla a
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Transgenic C57bl 6 Mice Expressing Hla A, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transgenic c57bl 6 mice expressing hla a/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
transgenic c57bl 6 mice expressing hla a - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Celero Systems Inc hla a ∗ 0201
Identification of SARS-CoV-2-specific T cell responses by pHLA class II <t>dextramers</t> (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across <t>all</t> <t>HLA-matched</t> donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.
Hla A ∗ 0201, supplied by Celero Systems Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hla a ∗ 0201/product/Celero Systems Inc
Average 86 stars, based on 1 article reviews
hla a ∗ 0201 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Identification of SARS-CoV-2-specific T cell responses by pHLA class II dextramers (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across all HLA-matched donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.

Journal: iScience

Article Title: Integrating complementary approaches reveals antigen-reactive CD4 + T cell states after SARS-CoV-2 vaccination

doi: 10.1016/j.isci.2026.116175

Figure Lengend Snippet: Identification of SARS-CoV-2-specific T cell responses by pHLA class II dextramers (A) UMAP with Leiden clusters (cluster names in UMAP, cluster numbers on the right) of CD4 + T cells enriched for pHLA dextramer-binding ( A) ( n = 4,882 cells). (B) Dot plots show the log-normalized expression of representative genes and centered log-ratio (CLR) transformed expression of surface proteins per cluster. Numbers on the left indicate cluster numbers. (C) Visualization of clone sizes for all cells in the UMAP. (D) Log-normalized expression of selected genes and scores. (E) Visualization of SARS-CoV-2 spike epitope-specific T cells (DPB1∗04:01/S 167 : n = 38) across all HLA-matched donors (CoVa-Adapt donors and HIM; n = 7) and screened time points. (F and G) UMAP visualization (F) and quantified fractional distribution (G) of DPB1∗04:01/S 167 -specific T cells of HLA-matched CoVa-Adapt donors excluding A7 due to breakthrough infection ( n = 5) at individual time points after primary (P), secondary (S), and tertiary (T) vaccination. Colors represent the cluster location of epitope-specific cells at the respective time points. Cells without the indicated epitope-specificity are shown in gray. Time points with no detected epitope-specific cells are indicated as n.d. (H) Similarity network of TCRs identified as reactive in the reverse phenotyping dataset (dark green) and of DPB1∗04:01/S 167 dextramer + TCR clones (orange) together with previously published SARS-CoV-2-specific TCRs (left). Each vertex in the similarity network represents a unique paired αβTCR clonotype, and edges connect vertices with ≤120 TCRdist units. Only clusters containing at least two clonotypes are shown. Colors indicate SARS-CoV-2 epitope-specificity and dataset origin. Clonotypes without assigned specificity in the published dataset are shown in gray. Clone IDs from our own datasets are provided for each vertex, with functionally tested clones highlighted in bold. Clones for which SARS-CoV-2 spike reactivity could be functionally validated are highlighted with a green asterisk, while non-reactive clones are marked by a red asterisk. Two clusters containing our reactive and DPB1∗04:01/S 167 -specific clones, together with spike-annotated published clones, are highlighted (left and right clusters). Sequence motifs of CDR3α and CDR3β regions for the highlighted clusters are shown on the right. Amino acid positions are indicated at the bottom of each plot. For the CDR3α region, the dominantly used V- and J-gene segments are indicated below the motifs. For detailed V- and J-gene segment usage, see I.

Article Snippet: For each cocktail, 1 μL per 5×10 6 cells of HLA-matched dCODE Dextramers (immudex) and 100 μM d-biotin (1/10 of total dextramer volume) were pre-mixed in FACS-buffer to block free binding sites.

Techniques: Binding Assay, Expressing, Transformation Assay, Infection, Clone Assay, Sequencing